...
首页> 外文期刊>Cornea >The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
【24h】

The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.

机译:术中使用丝裂霉素C切除有或没有角膜缘自体移植的眼表瘤形成。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To evaluate the efficacy of intraoperative mitomycin-C in excision of ocular surface neoplasia for prevention of recurrence. METHODS: Seven patients (eight eyes), three men and four women, aged 56 to 87 years (mean, 73.8 years), with lesions suspicious for corneal or conjunctival neoplasia, were operated on between October 1998 and March 2000. During excision of the lesion, mitomycin-C 0.02% was applied intraoperatively for 5 minutes. In two cases, excision was combined with conjunctival limbal autograft transplantation. All excised lesions were sent for histopathologic evaluation. RESULTS: During the follow-up period ranging from 6 to 28 months (mean, 16 months) one patient (one eye) died of an unrelated cause. Histopathologic study showed four cases of squamous cell carcinoma, one case of carcinoma in situ, two cases of dysplasia, and one case of actinic keratosis. Of the eight eyes, no clinical recurrence of the lesion occurred in seven eyes, whereas one eye with squamous cell carcinoma showed mild recurrence 5 months after surgery and was successfully treated with topical mitomycin-C. Up to the last follow-up of this case 10 months later, the lesion did not recur. CONCLUSION: The excision of conjunctival and corneal epithelial neoplasia combined with the intraoperative use of mitomycin-C seems to reduce the recurrence rate. The combined use of mitomycin-C and conjunctival limbal autograft transplantation in two cases did not alter the surgical outcome. More cases and a longer follow-up are needed to establish the efficacy of such an approach.
机译:目的:评估术中丝裂霉素C在切除眼表瘤形成中的作用,以预防复发。方法:1998年10月至2000年3月,对7例患者(八眼),三男四女,年龄56至87岁(平均73.8岁),其病变可疑为角膜或结膜瘤。术中应用0.02%丝裂霉素C损伤5分钟。在两个病例中,切除结合结膜缘自体角膜缘移植。所有切除的病灶均送去进行组织病理学评估。结果:在6到28个月(平均16个月)的随访期内,一名患者(一只眼睛)死于无关原因。组织病理学研究显示鳞状细胞癌4例,原位癌1例,发育异常2例,光化性角化病1例。在八只眼中,七只眼中未见该病的临床复发,而一只鳞状细胞癌的眼在手术后5个月显示出轻度复发,并已成功用局部丝裂霉素-C治疗。直到10个月后对该病例的最后一次随访,病变仍未复发。结论:结膜和角膜上皮瘤的切除结合术中使用丝裂霉素-C似乎降低了复发率。丝裂霉素-C联合结膜缘自体角膜缘移植的两例并没有改变手术效果。需要更多的病例和更长的随访时间来确定这种方法的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号